Khariga Jabbarli

Khariga Jabbarli

Auto-generated profile, based on publicly available information

Khariga Jabbarli

Department of Medical Genetics, Referans Clinical Laboratory Center , Baku, Azerbaijan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2020 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
DODemet Akdeniz Odemis
Demet Akdeniz Odemis
STSeref Bugra Tuncer
Seref Bugra Tuncer
AGArash Adamnejad Ghafour
Arash Adamnejad Ghafour
KJKhariga Jabbarli
Khariga Jabbarli
YGYasemin Gider
Yasemin Gider
HYHulya Yazici
Hulya Yazici
Purpose. Various molecular variations are known to result in different gene variants in the FGFR4 gene, known for its oncogenic transformation activity. The goal of this study was to investigate the FGFR4 p.Gly388Arg variant that plays role in the progression of cancer and retinal growth and may be an effective candidate variant in the Turkish population in retinoblastoma patients with no RB1 gene mutation. Methods. Using the Sanger sequencing methods, the FGFR4 p.Gly388Arg variant was bidirectionally sequenced in 49 patients with non-RB1 gene mutation in retinoblastoma patients and 13 healthy first-degree relatives and 146 individuals matched by sex and age in the control group. Results. In Turkish population-specific study, the FGFR4 p.Gly388Arg variant was found in 27 (55.1 percent) of 49 patients; mutation was found in 7 (53.8 percent) of these patients 13 healthy relatives screened. When FGFR4 p.Gly388Arg mutation status is evaluated in terms of 146 healthy controls, in 70 (47.9 percent) individuals, mutation was observed. Our analysis showed that the FGFR4 p.Gly388Arg allele frequency, which according to different databases is seen as 30 percent in the general population, is 50 percent common in the Turkish population. Conclusions. In patients with advanced retinoblastoma who were diagnosed with retinoblastoma prior to 24 months, the FGFR4 p.Gly388Arg allele was found to be significantly higher. As a result, these results indicate that the polymorphism of FGFR4 p.Gly388Arg may play a role in both the development of tumors and the progression of aggressive tumors.

11 September 2026 in Rheumatology
Verified
Journal Article
Open access
VGVafa Guliyeva
Vafa Guliyeva
GVGovhar Verdiyeva
Govhar Verdiyeva
LSLeyla Sahratova
Leyla Sahratova
FIFirengiz Ibrahimova
Firengiz Ibrahimova
AGAytac Guluzade
Aytac Guluzade
FDFatma Gül Demirkan
Fatma Gül Demirkan
Objectives: Familial Mediterranean fever (FMF) is highly prevalent in Mediterranean populations, yet data from Azerbaijan remain scarce despite its location within the traditional FMF belt. This study presents the first nationwide characterization of paediatric FMF in Azerbaijan. Methods: A multicentre retrospective cohort study was conducted across paediatric and genetic referral centres in 11 regions of Azerbaijan. Demographic, clinical and genetic data were analysed. Genotype–phenotype associations were evaluated, with particular emphasis on the distribution of variants across exons and the allelic burden of exon 10 variants. Results: A total of 349 paediatric patients (60.45% boys) were enrolled. The median age at symptom onset and diagnosis was 4 (0–18) and 7 (0–23) years, respectively. The most prevalent MEFV variants were M694V (47.3%), V726A (20.1%) and R202Q (19.8%). Zygosity distribution was 18.3% homozygous, 40% heterozygous and 41.5% compound heterozygous. Genotype–phenotype analyses included 329 patients after excluding isolated R202Q heterozygotes. Fever (79.3%) and abdominal pain (66.6%) were the most frequent manifestations. Compound heterozygous exon 10 genotypes were associated with earlier symptom onset in univariate analyses. In multivariable hierarchical logistic regression analyses, the presence of at least one M694V allele independently increased the likelihood of early-onset disease (odds ratio 2.10; 95% CI: 1.29, 3.43; P = 0.003), while the zygosity-based model supported an association between biallelic exon 10 involvement and early disease onset. Conclusion: This first nationwide paediatric FMF study from Azerbaijan reveals substantial regional genetic heterogeneity, with compound heterozygosity associated with earlier disease onset. These findings advance FMF epidemiology in the Caucasus and support improved genetic counselling and surveillance for high-risk genotypes.